Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27,453Revenue $M1,212Net Margin (%)-127.3Z-Score13.1
Enterprise Value $M26,891EPS $-2.0Operating Margin %-119.4F-Score2
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-126.7Higher ROA y-yN
Price/Book25.010-y EBITDA Growth Rate %0Quick Ratio3.7Cash flow > EarningsY
Price/Sales46.25-y EBITDA Growth Rate %0Current Ratio3.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-32.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-61.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M241ROI % (ttm)-31.5Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXKen Fisher 2014-09-30 Reduce$84.74 - $113.9
($94.97)
$ 114.1420%Reduce -31.99%4,593
VRTXKen Fisher 2014-06-30 Buy $62.44 - $93.77
($69.73)
$ 114.1464%New holding, 6753 sh.6,753
VRTXJohn Burbank 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 114.1464%Sold Out0
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 114.1464%Sold Out0
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 114.1444%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 114.1444%New holding, 10000 sh.10,000
VRTXJohn Burbank 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 114.1444%New holding, 2872 sh.2,872
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 114.1464%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 114.1443%Add 19%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 114.1455%Add 140.58%5,990,000
VRTXAndreas Halvorsen 2013-06-30 Sold Out -0.26%$52.6 - $85.6
($73.64)
$ 114.1455%Sold Out0
VRTXNWQ Managers 2013-06-30 Sold Out -0.09%$52.6 - $85.6
($73.64)
$ 114.1455%Sold Out0
VRTXAndreas Halvorsen 2013-03-31 Buy 0.26%$41.9 - $54.97
($47.91)
$ 114.14138%New holding, 780500 sh.780,500
VRTXNWQ Managers 2013-03-31 Reduce-0.02%$41.9 - $54.97
($47.91)
$ 114.14138%Reduce -23.44%191,032
VRTXDaniel Loeb 2012-12-31 Sold Out -0.77%$38.88 - $59.42
($46.08)
$ 114.14148%Sold Out0
VRTXJohn Burbank 2012-12-31 Sold Out -0.38%$38.88 - $59.42
($46.08)
$ 114.14148%Sold Out0
VRTXDaniel Loeb 2012-09-30 Add0.22%$48.38 - $59.07
($53.5)
$ 114.14113%Add 40%700,000
VRTXJohn Burbank 2012-09-30 Reduce-0.09%$48.38 - $59.07
($53.5)
$ 114.14113%Reduce -25%150,000
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 114.14113%Sold Out0
VRTXJoel Greenblatt 2012-09-30 Sold Out -0.08%$48.38 - $59.07
($53.5)
$ 114.14113%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRTX Ken Fisher 2014-12-314,37800-4.68%
VRTX Vanguard Health Care Fund 2014-09-3011,807,5004.913.4
VRTX Ken Fisher 2014-09-304,59300-31.99%
Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Silva Paul MSVP & Corp Controller 2015-01-26Sell1,125$125.62-9.14view
BOGER JOSHUA SDirector 2015-01-21Sell10,500$125.08-8.75view
SACHS BRUCE IDirector 2015-01-20Sell139$125-8.69view
BOGER JOSHUA SDirector 2015-01-14Sell10,500$120.16-5.01view
Silva Paul MSVP & Corp Controller 2015-01-13Sell1,125$121.92-6.38view
Sachdev AmitEVP, Policy, Access & Value 2015-01-09Sell12,000$125-8.69view
SACHS BRUCE IDirector 2015-01-09Sell9,861$125.04-8.72view
Riley Wayne JosephDirector 2015-01-09Sell10,000$125-8.69view
BOGER JOSHUA SDirector 2015-01-07Sell10,500$119.32-4.34view
Chodakewitz JeffreyEVP GMDA, CMO 2015-01-02Sell2,291$122.54-6.85view

Press Releases about VRTX :

Quarterly/Annual Reports about VRTX:

News about VRTX:

Articles On GuruFocus.com
J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 
Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 
Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 
Idenix Pharmaceuticals Lagging Behind in Breakthrough Hepatitis C Drug Development Jul 13 2012 
Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 
Vertex Could Climb On New Drug, VX-222 Success Apr 21 2012 

More From Our Partners
Will Vertex (VRTX) Surprise with a Lower Loss in Q4? - Analyst Blog Jan 27 2015 - ZACKS

More From Other Websites
Baird Releases Comments After Vertex Earnings Call Jan 29 2015
Vertex head of research, Broad co-founder David Altshuler to meet with Obama Friday Jan 29 2015
Vertex Pharma Verging on Full Valuation Jan 29 2015
Maxim Downgrades Vertex Pharmaceuticals After Earnings Jan 29 2015
Vertex Pharmaceutical (VRTX) Stock Declines Today Following Earnings Realease Jan 29 2015
Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog Jan 29 2015
Vertex Pharm downgraded by Needham and Maxim Group Jan 29 2015
Vertex Pharmaceuticals Beats Q4 Revenue Expectations Jan 28 2015
Drugmakers get mysterious invites to White House Jan 28 2015
Vertex Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today Jan 28 2015
Regeneron, Vertex execs heads to White House Jan 28 2015
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 28 2015
Vertex reports 4Q loss Jan 28 2015
Vertex reports 4Q loss Jan 28 2015
Vertex Reports Full-Year and Fourth Quarter 2014 Financial Results and Provides Guidance for 2015 Jan 28 2015
4:07 pm Vertex Pharm misses by $0.09, beats on revs Jan 28 2015
Vertex Reports Full-Year and Fourth Quarter 2014 Financial Results and Provides Guidance for 2015 Jan 28 2015
Q4 2014 Vertex Pharmaceuticals Inc Earnings Release - After Market Close Jan 28 2015
Up to Speed: Peltz receives ammo in fight against DuPont (Video) Jan 28 2015
Will Vertex (VRTX) Surprise with a Lower Loss in Q4? - Analyst Blog Jan 27 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK